These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6980218)

  • 1. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
    Carrizosa J; Kobasa WD; Snepar R; Kaye KM; Kaye D
    J Antimicrob Chemother; 1982 May; 9(5):387-93. PubMed ID: 6980218
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J; Santoro J; Kaye D
    Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.
    Nannini EC; Singh KV; Murray BE
    Clin Infect Dis; 2003 Nov; 37(9):1194-8. PubMed ID: 14557964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Miller WR; Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Miller MH
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefazolin therapy for Staphylococcus aureus bacteremia.
    Fernández-Guerrero ML; de Górgolas M
    Clin Infect Dis; 2005 Jul; 41(1):127. PubMed ID: 15937778
    [No Abstract]   [Full Text] [Related]  

  • 10. Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C β-Lactamases.
    George CRR; Lahra MM; Nguyen T; Gatus B
    Microbiol Spectr; 2023 Aug; 11(4):e0022023. PubMed ID: 37409947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefazolin and Staphylococcus aureus endocarditis.
    Kaye D; Hewitt W; Remington JS; Turck M
    JAMA; 1977 Jun; 237(24):2601. PubMed ID: 576979
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.
    Baker RL; Fass RJ
    Antimicrob Agents Chemother; 1984 Aug; 26(2):231-4. PubMed ID: 6385840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1988 Feb; 32(2):262-4. PubMed ID: 3163241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
    Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D
    Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsuccessful treatment of staphylococcal endocarditis with cefazolin.
    Bryant RE; Alford RH
    JAMA; 1977 Feb; 237(6):569-70. PubMed ID: 576284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA; Johnson ML
    J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of staphylococcal endocarditis.
    Bryant RE; Alford RH
    JAMA; 1978 Mar; 239(12):1130-1. PubMed ID: 628061
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.